Insulet Announces Full Market Release of Omnipod® 5 Automated Insulin Delivery System

Omnipod 5 is Now Fully Available through Retail Pharmacy Channels ACTON, Mass.–(BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its Omnipod® 5 Automated Insulin Delivery (AID) System (Omnipod 5) is now fully available through U.S. retail pharmacy channels … [Read more…]

Graminex®, L.L.C. Completes Clinical Trial with Graminex® Flower Pollen Extract Focusing on Women’s Urinary Incontinence with Positive Results.

DESHLER, Ohio–(BUSINESS WIRE)–#flowerpollenextract–Graminex®, L.L.C. is pleased to announce it has completed a clinical study with Graminex® Flower Pollen Extract for women’s urinary incontinence and urinary health with positive results. This study was conducted as a randomized, double-blind, placebo-controlled, study to investigate the effectiveness of Graminex® Flower Pollen Extracts in 190 healthy women with urinary incontinence. … [Read more…]

Selective Estrogen Receptor Degraders Drug Pipeline Research Report 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Selective estrogen receptor degraders – Pipeline Insight, 2022” clinical trials has been added to ResearchAndMarkets.com’s offering. This “Selective Estrogen Receptor Degraders – Pipeline Insight, 2022” report provides comprehensive insights about 14+ companies and 14+ pipeline drugs in the Selective Estrogen Receptor Degraders pipeline landscape. It covers the pipeline drug profiles, including clinical and … [Read more…]

NanOlogy Publishes Results from a Phase 1/2 Clinical Trial of Large Surface Area Microparticle Docetaxel in High-Risk Non-Muscle Invasive Bladder Cancer

FORT WORTH, Texas–(BUSINESS WIRE)–NanOlogy LLC, a clinical-stage interventional oncology drug company, announced today that results from a clinical trial of Large Surface Area Microparticle Docetaxel (LSAM-DTX) in High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) have been published in The Journal of Urology®. The research article entitled Phase 1/2 Trial Results of a Large Surface Area Microparticle … [Read more…]

Global Medical Imaging Informatics Markets, 2021-2028 – Rising Demand for AI- and Cloud-Based Platforms & Technological Advancements in Medical Imaging Informatics – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Medical Imaging Informatics Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Type, Application, and Components” report has been added to ResearchAndMarkets.com’s offering. The global medical imaging informatics market is expected to grow from US$ 3,671.72 million in 2021 to US$ 5,175.39 million by 2028; it is estimated to grow … [Read more…]

SmartLabs Announces Plans to Expand High-Performance Laboratory Facilities in Philadelphia

– State-of-the-art laboratory space will become available in 2025 – New building will bring SmartLabs to its third city in the United States BOSTON–(BUSINESS WIRE)–Capitalizing on Philadelphia’s emergence as a national hub for cell and gene therapy, SmartLabs, a Boston-based Laboratory-as-a-Service (LaaS) leader, today announced plans to open its first facility in the city in … [Read more…]

Hospital-Acquired Disease Testing Market Analysis Report 2022 – Global Forecast to 2029 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Hospital-Acquired Disease Testing Market Analysis by Test Type (Pneumonia Stents, Urinary Tract Infection, Blood Stream Infection, Surgical Site Infection, Methicillin-Resistant Staphylococcus Aureus), and by Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The global hospital-acquired disease testing market size is estimated to be USD 1,500.4 million in 2021 and … [Read more…]

TNF Alpha Inhibitors Global Market Research Report 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “TNF Alpha Inhibitors Global Market Report 2022: By Drug, By Route, By Disease” report has been added to ResearchAndMarkets.com’s offering. The global TNF Alpha Inhibitors market is expected to grow from $38.56 billion in 2021 to $40.73 billion in 2022 at a compound annual growth rate (CAGR) of 5.6%. The market is expected … [Read more…]

CrestOptics’ DeepSIM Super Resolution Confocal Microscope Module Named by Microscopy Today as a Top 10 Best Microscopy Innovation Of 2022

Innovation awards announced at 2022 Microscopy & Microanalysis Meeting, Portland, Oregon, 31st July – 4th August, 2022 ROME–(BUSINESS WIRE)–CrestOptics S.p.A., a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and diagnostic applications, has been recognised as developing one of the ten best microscopy innovations in the 2022 Microscopy Today Innovation Awards, DeepSIM. … [Read more…]

RWS joins the Electronic Clinical Outcome Assessment (eCOA) Consortium

RWS’s Life Sciences team will work with consortium members to drive innovation, best practice and adoption of eCOA within clinical trials CHALFONT ST PETER, England–(BUSINESS WIRE)–RWS, a unique, world-leading provider of technology-enabled language, content and intellectual property services, today announces that it has joined Critical Path Institute’s Electronic Clinical Outcome Assessment (eCOA) Consortium to help … [Read more…]